Lupin announces completion of buyback of shares by Multicare Pharmaceuticals Philippines, Inc.

Lupin announced that Multicare Pharmaceuticals Philippines, Inc. (MPPI), a subsidiary of Nanomi B.V., the Netherlands (Nanomi), which is a wholly owned subsidiary of the Company, has completed the buy-back of the balance 30,559 shares.

Consequently, effective 01 October 2026, MPPI has become a wholly owned subsidiary of Nanomi and step-down wholly owned subsidiary of the Company.